Dr Gill Barnett

University of Cambridge

University departments
Department of Oncology
NHS or other affiliations
Strangeways Research Laboratory

Position: Clinical Research Fellow
Personal home page: http://www.srl.cam.ac.uk/

PubMed journal articles - click here

Research description

Increased understanding of the genetic basis for the wide variation between patients in the severity of late radiotherapy toxicity.

Research Programme or Virtual Institute
Thoracic Cancer
Strategic Resources
CRUK RadNet Cambridge

Key publications

1.Barnett GC, West CM, Dunning AM, RM. Elliott, CE Coles, PDP Pharoah, NG Burnet. 2009 Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer 9:134-42. 2.Barnett GC, Wilkinson J, Moody AM, Wilson, CB, Sharma, Klager S, Hoole AC, Twyman N, Burnet NG, Coles CE. A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: baseline characteristics and dosimetry results. Radiother Oncol 92:34-41, 2009. 3.Barnett GC, Coles CE, Burnet NG, PD Pharoah, J Wilkinson, West CM, Baynes C, Dunning AM. 2010 No association between SNPs regulating TGF-beta1 secretion and late radiotherapy toxicity to the breast: Results from the RAPPER study. Radiother Oncol (e-pub).